Collaboration between giant pharmaceutical corporations and patients with very little power just doesn’t work, according to ...

Treatments like GLP-1s are effective, but they're also extremely expensive. With GLP-1s rising in demand, it can pose a ...

The agency took the unusual step based on what it called a severely lacking response by sheriff’s deputies to Keith Galen ...

Researchers have discovered that remodeling of extracellular matrix (ECM) in the hypothalamus, specifically around AgRP ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 586.36% and ...

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

Some things should be consumed with caution, while others need to be avoided entirely – these are the most serious offenders ...

Even without Pension Credit, you can still qualify for the incentive if your household income is less than £31,000 and ...

The first crystal structure of an alternative DNA shape from the insulin gene has been revealed by a UCL-led research team.

Most trillion-dollar companies today are in the technology sector, but one particular healthcare stock is knocking on the ...

For years, the question of whether to take medication to lower high blood pressure had been partly answered by a tool that calculated someone’s 10-year risk of having a heart attack or stroke.